Citizens Financial Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,300
Closed -$555K 859
2025
Q4
$555K Sell
48,300
-3,566
-7% -$55.1K 0.01% 521
2025
Q3
$1.26M Buy
+51,866
New +$864K 0.02% 354

Other funds holding CDLX

Citizens Financial Group's CDLX Position: Q1 2026 in Review

Citizens Financial Group sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 48,300 shares — an estimated $555K sold.

Citizens Financial Group first reported a position in CDLX in Q3 2025 and held it in 2 quarters. The position peaked at $1.26M in Q3 2025. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Citizens Financial Group reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Citizens Financial Group sold 48,300 Cardlytics shares in Q1 2026, an estimated $555K.
  • Citizens Financial Group first reported a position in Cardlytics in Q3 2025 and held it in 2 quarters.
  • Citizens Financial Group's Cardlytics position peaked at $1.26M in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.